573 related items for PubMed ID: 12746659
1. [Anti-phospholipid syndrome nephropathy].
Nochy D, Daugas E, Hill G, Piette JC.
Ann Med Interne (Paris); 2003 Feb; 154(1):51-8. PubMed ID: 12746659
[Abstract] [Full Text] [Related]
2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[Abstract] [Full Text] [Related]
3. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus.
Daugas E, Nochy D, Huong DLT, Duhaut P, Beaufils H, Caudwell V, Bariety J, Piette JC, Hill G.
J Am Soc Nephrol; 2002 Jan; 13(1):42-52. PubMed ID: 11752020
[Abstract] [Full Text] [Related]
4. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P.
Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
[Abstract] [Full Text] [Related]
5. [Clinical manifestations of APS-nephropathy in primary antiphospholipid syndrome].
Shilov EM, Kozlovskaia NL, Meteleva NA, Kozlovskaia LV, Varshavskiĭ VA, Miroshnichenko NG, Blokhina GV, Serova AG, Nesterova SG, Smolianitskiĭ AIa.
Ter Arkh; 2003 Oct; 75(6):22-7. PubMed ID: 12920954
[Abstract] [Full Text] [Related]
6. Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS.
Tektonidou MG, Sotsiou F, Moutsopoulos HM.
J Rheumatol; 2008 Oct; 35(10):1983-8. PubMed ID: 18688914
[Abstract] [Full Text] [Related]
7. Antiphospholipid antibodies and renal involvement.
Gigante A, Gasperini ML, Cianci R, Barbano B, Giannakakis K, Di Donato D, Fuiano G, Amoroso A.
Am J Nephrol; 2009 Oct; 30(5):405-12. PubMed ID: 19713697
[Abstract] [Full Text] [Related]
8. [Kidney damage in primary antiphospholipid syndrome].
Kozlovskaia NL, Tareeva IE, Kamyshova ES, Varshavskiĭ VA, Miroshnichenko NG, Kotliarova GV.
Ter Arkh; 2001 Oct; 73(6):25-31. PubMed ID: 11521516
[Abstract] [Full Text] [Related]
9. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[Abstract] [Full Text] [Related]
10. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome].
Kozlovskaia NL, Kabaenkova GS, Varshavskiĭ VA, Shvetsov MIu.
Klin Med (Mosk); 1995 Sep; 73(3):93-6. PubMed ID: 8577127
[Abstract] [Full Text] [Related]
11. Significance of antiphospholipid antibodies in lupus nephritis.
Natejumnong C, Ruangkanchanasetr P, Aimpun P, Supaporn T.
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
[Abstract] [Full Text] [Related]
12. Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study.
Erre GL, Bosincu L, Faedda R, Fenu P, Masala A, Sanna M, Taras L, Longu MG, Piras M, Soro G, Satta AE, Passiu G.
Rheumatol Int; 2014 Apr; 34(4):535-41. PubMed ID: 24232504
[Abstract] [Full Text] [Related]
13. Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE).
Miranda JM, Jara LJ, Calleja C, Saavedra MA, Bustamante RM, Angeles U.
Reumatol Clin; 2009 Apr; 5(5):209-13. PubMed ID: 21794612
[Abstract] [Full Text] [Related]
14. Antiphospholipid antibodies and the kidney.
Asherson RA, Kant KS.
J Rheumatol; 1993 Aug; 20(8):1268-72. PubMed ID: 8230004
[No Abstract] [Full Text] [Related]
15. [Antiphospholipid syndrome and stroke].
Kitagawa Y.
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[Abstract] [Full Text] [Related]
16. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
Sipek-Dolnicar A, Hojnik M, Rozman B, Vizjak A, Ferluga D.
Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):707-10. PubMed ID: 11020961
[Abstract] [Full Text] [Related]
17. [Antiphospholipid syndrome--the description of two cases].
Podrazilová L, Peterová V, Olejárová M, Seidl Z, Dostál C.
Vnitr Lek; 2006 Jan 25; 52(1):89-94. PubMed ID: 16526206
[Abstract] [Full Text] [Related]
18. [Primary antiphospholipid syndrome].
Popa A, Voinea L, Pop M, Stana D, Dascalu AM, Alexandrescu C, Ciuluvica R.
Oftalmologia; 2008 Jan 25; 52(1):13-7. PubMed ID: 18714484
[Abstract] [Full Text] [Related]
19. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
J Rheumatol; 2009 Jun 25; 36(6):1195-9. PubMed ID: 19447935
[Abstract] [Full Text] [Related]
20. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.
Silvariño R, Sant F, Espinosa G, Pons-Estel G, Solé M, Cervera R, Arrizabalaga P.
Lupus; 2011 Jun 25; 20(7):721-9. PubMed ID: 21486929
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
